Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Net Cash Flow: 2019-2024

Historic Net Cash Flow for LifeStance Health (LFST) over the last 5 years, with FY2024 value amounting to $75.7 million.

  • LifeStance Health's Net Cash Flow fell 429.5% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.3 million, marking a year-over-year increase of 6878.52%. This contributed to the annual value of $75.7 million for FY2024, which is 35421.02% up from last year.
  • LifeStance Health's Net Cash Flow amounted to $75.7 million in FY2024, which was up 35421.02% from -$29.8 million recorded in FY2023.
  • LifeStance Health's 5-year Net Cash Flow high stood at $129.2 million for FY2021, and its period low was -$39.4 million during FY2022.
  • Moreover, its 4-year median value for Net Cash Flow was $23.0 million (2023), whereas its average is $33.9 million.
  • Per our database at Business Quant, LifeStance Health's Net Cash Flow plummeted by 13050.15% in 2022 and then surged by 35421.02% in 2024.
  • Over the past 4 years, LifeStance Health's Net Cash Flow (Annual) stood at $129.2 million in 2021, then plummeted by 130.5% to -$39.4 million in 2022, then grew by 24.39% to -$29.8 million in 2023, then surged by 354.21% to $75.7 million in 2024.
  • Its last three reported values are $75.7 million in FY2024, -$29.8 million for FY2023, and -$39.4 million during FY2022.